Welcome to our dedicated page for Innospec SEC filings (Ticker: IOSP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Locating sulfur-additive margins or tracking drilling-fluid risks in Innospec鈥檚 disclosures can feel like chemistry lab work. Each 10-K, 10-Q, or 8-K packs dense environmental data, raw-material cost tables, and global plant statistics that busy analysts struggle to decode.
Stock Titan鈥檚 AI solves that problem. Our platform turns every Innospec SEC filing into plain-English insights. Want the Innospec annual report 10-K simplified? We highlight segment revenue and emission liabilities in seconds. Need the latest Innospec quarterly earnings report 10-Q filing? AI pulls out surfactant volume trends while you sip coffee. Curious about Innospec 8-K material events explained? AG真人官方-time alerts flag refinery outages or leadership changes before markets react.
The page updates the moment EDGAR releases anything鈥攚hether it鈥檚 Innospec insider trading Form 4 transactions or a definitive proxy detailing executive incentives. You鈥檒l find:
- Form 4 dashboards for Innospec executive stock transactions Form 4 with instant email and SMS alerts鈥攑erfect for tracking buying or selling by key chemists and officers.
- AI-written summaries that make understanding Innospec SEC documents with AI as simple as reading a headline.
- Side-by-side redlines that power deeper Innospec earnings report filing analysis across quarters.
Whether you鈥檙e assessing compliance costs, monitoring Innospec proxy statement executive compensation, or just need Innospec SEC filings explained simply, Stock Titan delivers every disclosure鈥攄ecoded and delivered in real time.
Innospec鈥檚 Q2 2025 10-Q shows mixed performance. Net sales rose 1% YoY to $439.7 m, but net income fell 25% to $23.5 m (EPS $0.94). Lower profitability stemmed from a 120 bp drop in aggregate gross margin to 28.0% and a 3% rise in operating expenses; operating income declined 16% to $34.3 m.
Segment results were uneven: Fuel Specialties boosted gross margin 350 bp to 38.1% and operating income 16% to $35.4 m, while Performance Chemicals margin contracted 510 bp and Oilfield Services revenue fell 7%. For the first half, sales slipped 6% to $880.5 m and net income dropped 22% to $56.3 m (diluted EPS $2.24).
Cash from operations shrank to $37.6 m (-56% YoY) as inventories climbed $35.8 m. Nevertheless, cash & equivalents remain solid at $266.6 m; the $250 m revolver is undrawn and the company carries no long-term debt. Equity improved to $1.30 bn on retained earnings and a $57.6 m favorable FX translation adjustment.
Capital deployment included $32.2 m of capex/ERP spend, $20.8 m dividends ($0.84 / share) and $13.3 m share buybacks under a new $50 m program. Plant-closure provisions were raised $4.1 m and FX hedges produced a $6.4 m loss. Management cites softer demand in Oilfield Services and price pressure in Performance Chemicals, but highlights margin gains in Fuel Specialties and low leverage.